1/75
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Adrenergic Receptor Subtypes
alpha-1
in blood vessels
excitatory
vasoconstriction of arteries/arterioles
increases BP and SVR
alpha-2
in autonomic ganglia and CNS
inhibitory autoreceptor
inhibits release further release of NE, Ach, and insulin to prevent overstimulation
beta-1
in heart
excitatory
inotropic (contractility) + chronotropic (HR)
increases renin
beta-2
in lungs/muscles
inhibitory/excitatory
vasodilation + bronchodilation
increases glucagon
Adrenergic Agonists
Phenylephrine
alpha 1 >
nasal decongestant, vasopressor
Clonidine
alpha 2 >
centrally acting antihypertensive, alcohol/BZD withdrawal, chronic pain
inhibitory effect
dexmedetomidine
alpha 2 >
ICU sedation
NE
predominantly alpha 1 (some beta-1)
vasopressor (vasoconstricts + increases HR)
epinephrine low dose
0.01 - 0.05: beta effect (increase CO, decrease SVR)
vasopressor, anaphylaxis, asthma
epinephrine high dose
0.05+: alpha-1 > (increase SVR)
vasopressor, anaphylaxis, asthma
dobutamine
beta 1 >
inotrope (increases contractility)
isoproterenol
beta 1 = beta 2 > alpha
inotrope (increases contractility)
albuterol
beta-2 >
bronchodilator for acute asthma
dopamine low dose
2 - 5
D1 receptor
renal vasodilation
improve urine output
dopamine medium dose
5 - 10
beta 1 + D1 (inotropic, chronotropic + renal vasodilation, improve urine output)
dopamine high dose
1 - 20
alpha-1 (vasoconstriction, increase BP, SVR)
Adrenergic Antagonists
Prazosin, Terazosin, Doxazosin
alpha 1 >
antihypertensives
lowe BP by relaxing blood vessels
Tamsulosin
alpha 1 >
manages BPH
Yohimbine
alpha 2 >
supplement for ED/stimulant
blocks alpha-2 → no inhibitory effect → continued NE release → increases BP
Labetalol and Carvedilol
beta 1 = beta 2 >/= alpha 1 > alpha 2
non selective beta blocker w/ alpha 1 blocking
decreases BP (decrease HR + vasodilation)
which drug improves heart failure survival?
Carvedilol
Metoprolol and Atenolol
beta 1 >
selective
treats HTN and arrhythmia (reduces HR)
Propranolol
beta 1 = beta 2
nonselective
HTN and arrhythmia
used for migraines because it it lipophilic and crosses BBB easily
renin
protect against hypotension
low BP → activate RAAS → increase BP
renin released as
pro-renin
actions of angiotensin II
vasoconstriction
increases PVR and BP
aldosterone release
ADH release
increase sympathetic activity
actions of aldosterone
promote sodium reabsorption in exchange for potassium excretion
water reabsorption → increase blood volume → BP increase
release ADH
Captopril, Lisinopril, Enalapril
class
MOA
ACEis
MOA
inhibit ACE = prevent conersion to Ang II
vasodilation, decreased aldosterone, less Na/water retention
1st line
“prils”
ACEi also inhibits
breakdown of bradykinin
more bradykinin → cough side effect
Enalaprilat
IV
metabolite of oral Enalapril (prodrug)
Azilartan, Candesartan, Olmesartan, etc
class
MOA
angiotensin II receptor blockers (ARBs)
MOA
prevent Ang II from binding
no aldosterone release → no vasoconstrictor effect
“sartans”
Aliskiren
class
MOA
renin inhibitor
directly inhibit renin activity (not pro-renin)
not 100% effective
Spironolactone
class
MOA
type of diuretic
aldosterone antagonist
block aldosterone receptor in kidney → prevent Na reabsorption
K+ sparing diuretic
hyperkalemia
which drugs cause?
high risk in?
high potassium
ACEis, ARBs, aldosterone antagonists
low aldosterone → less Na/K exchange → conserves K+
HF and CKD
ACEi specific ADEs
dry cough
angioedema = allergic swelling of soft tissues
both due to increase of bradykinin
HTN: Diuretics
what do diuretics do?
promote Na and H2O excretion
decrease blood volume → decrease BP
water needs —— to be reabsorbed
aquaporin channels
Acetazolamide
class
MOA
effect
use
carbonic anhydrase inhibitors
inhibit carbonic anhydrase in PCT
prevent bicarbonate and Na+ reabsorption
weak diuretic
loss of bicarbonate → lead to acidic blood (acidosis)
patients w/ metabolic alkalosis
Furosemide, Bumetanide, Torsemide
class
MOA
effect
side effects
loop diuretics
inhibit Na/K/Cl symporter in thick ascending loop
lose Na (no reabsorption) → diuretic effect
most powerful diuretic
major loss of Na, K, Ca, Mg
hypokalemia, hypocalcemia, hypomagnesia
Hydrochlorothiazide, Chlorthalidone
class
MOA
preferred in…
side effects
thiazide and thiazide-like diuretic
inhibit Na/Cl symporter in DCT
HTN
hypokalemia, hypercalcemia, hyperuricemia
what to use instead of thiazides if pt has sulfa allergy?
ethacrynic acid
2 types of potassium sparing diuretics
Na channel antagonist
aldosterone antagonist
potassium sparing diuretics
what it increases?
target?
combined?
increase K levels
targets collecting tubule
combined w/ loop and thiazide
Amiloridine, Triamterene
class
MOA
effect
Na channel antagonists
block Na channel → no Na reabsorption → no exchange w/ K
weak diuretic effect
Spironolactone
Aldosterone
MOA
side effects
aldosterone antagonists
block aldosterone receptor → No Na/K exchange
Spironolactone
gynecomastia > >
epelerenone
hyperkalemia > >
hyperkalemia, hyperuricemia
Mannitol
class
MOA
osmotic diuretic
prevent water reabsorption
non-DHPs
drugs
target
for what?
Verapamil, Diltiazem
affects heart
slows HR and contractility
for arrythmias
DHP
drugs
target
for what?
Amlodipine, Nifedipine (“pines”)
vasodilation of arteries/arterioles
for HTN
DHP selectivity
in smooth muscle
vasodilation → lower BP
can cause reflex tachycardia
reflex tachycardia
sudden drop in BP from vasodilation sensed by baroreceptors → trigger compensatory increase in HR
use Amlodipine to reduce this effect
non-DHP selectivity
equipotent for cardiac tissue and vasculature
SA node
block Ca entry → decreased HR
cardiac myocytes
block Ca entry → decreased contractility
non-DHP ADEs
bradycardia
AV block
worsening of systolic HF
Precautions/CIs of CCBs
avoid in HFrEF
avoid non-DHPs in pts w/ 2nd or 3rd degree AV block
avoid short-acting DHPs due to risk of profound hypotension and reflex tachycardia
Beta Blockers
Labetalol
non-selective beta-blocker and alpha blocker
added vasodilatory effect
IV in hypertensive emergencies
Carvedilol
non-selective beta-blocker and alpha blocker
for HF
oral
Atenolol and Metoprolol
beta-1 selective (cardioselective)
widely used for HTN and HF
cautions of beta blockers
avoid abrupt discontinuation
rebound HTN
tachycardia
renal dysfunction
reduce dose
DDI of beta blockers
non-DHP (Verapamil, Diltiazem)
cause heart block and hypotension
avoid beta blockers in
sinus bradycardia
heart block
asthma
ADE of beta blockers
bradycardia/conduction abnormalities
bronchospasm (non-selective)
fatigue, dizziness
Alpha blockers
MOA
example
vasodilation of arteries
“zosin” — Prazosin, Doxazosin, Terazosin
which patients benefit from alpha blockers?
BPH — benign prostatic hyperplasia
ADE of alpha blockers
1st dose phenomenon
significant drop in BP (hypotension) and reflex tachy after 1st dose
orthostatic hypotension
take at bedtime to minimize risk
edema
DDI of alpha blockers
phosphodiesterase-5 inhibitors
additive hypotensive effect
centrally acting antihypertensives
alpha-2 receptor agonists in CNS
clonidine, methyldopa
inhibit NE release → reduce sympathetic outflow → vasodilation → reduce BP
centrally acting antihypertensives Place in therapy
clonidine
resistant HTN
methyldopa
pregnancy-induced HTN
ADE of centrally acting antihypertensives
edema (worse in methyldopa)
orthostatic hypotension
direct vasodilators
MOA
act directly on smooth muscle of blood vessels → vasodilation by
hyperpolarization → open K+ channels
- release nitric oxide (NO)
hydralazine
vasodilator
preferred in CKD or renal failure → increases renal blood flow
Minoxidil is
not 1st line
ADE of vasodilators
reflex tachycardia
edema
drug induced lupus (hydralazine) but reversible
hirsutism (minoxidil) (hair growth)